EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana

Kofi Effah iD, Ethel Tekpor, Comfort Mawusi Wormenor, Joseph Emmanuel Amuah, Nana Owusu Essel iD, Bernard Hayford Atuguba, Gifty Belinda Klutsey, Edna Sesenu, Georgina Tay, Faustina Tibu, Seyram Kemawor iD, Isaac Gedzah und 3 weitere

PLOS Global Public Health · 20.04.2023 · 3 (4) · e0001830

DOI: 10.1371/journal.pgph.0001830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Global Public Health, online erschienen am 20.04.2023. Verfasst von Kofi Effah und 14 weiteren Autor:innen. Beteiligte Einrichtung: Catholic Hospital, Battor, via Sogakope, Volta Region, Ghana. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytology-based cervical cancer screening programs have been difficult to implement and scale up in developing countries. Thus, the World Health Organization recommends a ‘see and treat’ approach by way of hr-HPV testing and visual inspection. We aimed to evaluate concurrent HPV DNA testing and visual inspection in a real-world low-resource setting by comparing the detection rates of concurrent visual inspection with dilute acetic acid (VIA) or mobile colposcopy and hr-HPV DNA testing to standalone hr-HPV DNA testing (using the care HPV, GeneXpert, AmpFire, or MA-6000 platforms). We further compared their rates of loss to follow-up. This retrospective, descriptive cross-sectional study included all 4482 women subjected to cervical precancer screening at our facility between June 2016 and March 2022. The rates of EVA and VIA ‘positivity’ were 8.6% (95% CI, 6.7–10.6) and 2.1 (95% CI, 1.6–2.5), respectively, while the hr-HPV-positivity rate was 17.9% (95% CI, 16.7–19.0). Overall, 51 women in the entire cohort tested positive on both hr-HPV DNA testing and visual inspection (1.1%; 95% CI, 0.9–1.5), whereas a large majority of the women tested negative (3588/4482, 80.1%) for both and 2.1% (95% CI, 1.7–2.6) tested hr-HPV-negative but visual inspection ‘positive’. In total, 191/275 (69.5%) participants who tested hr-HPV positive on any platform, as a standalone test for screening, returned for at least one follow-up visit. In light of factors such as poor socioeconomic circumstances, additional transportation costs associated with multiple screening visits, and lack of a reliable address system in many parts of Ghana, we posit that standalone HPV DNA testing with recall of hr-HPV positives will be tedious for a national cervical cancer prevention program. Our preliminary data show that concurrent testing (hr-HPV DNA testing alongside visual inspection by way of VIA or mobile colposcopy) may be more cost-effective than recalling hr-HPV-positive women for colposcopy.

Autor:innen und Institutionen

  • Catholic Hospital, Battor, via Sogakope, Volta Region, Ghana.
  • School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Department of Emergency Medicine, College of Health Sciences, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
  • Department of Pathology, University of Cape Coast, School of Medical Sciences, Clinical Teaching Center, Cape Coast, Ghana.

ORCID-Profile: Kofi Effah, Nana Owusu Essel, Seyram Kemawor

Zitieren

APA

Effah, K., Tekpor, E., Wormenor, C. M., Amuah, J. E., Essel, N. O., Atuguba, B. H., Klutsey, G. B., Sesenu, E., Tay, G., Tibu, F., Kemawor, S., Gedzah, I., Morkli, E. A. C., Danyo, S., & Akakpo, P. K. (2023). Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana. PLOS Global Public Health, 3(4), e0001830. https://doi.org/10.1371/journal.pgph.0001830

Vancouver

Effah K, Tekpor E, Wormenor CM, Amuah JE, Essel NO, Atuguba BH, et al. Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana. PLOS Global Public Health. 2023;3(4):e0001830. doi:10.1371/journal.pgph.0001830

BibTeX
@article{Effah2023,
  author = {Effah, Kofi and Tekpor, Ethel and Wormenor, Comfort Mawusi and Amuah, Joseph Emmanuel and Essel, Nana Owusu and Atuguba, Bernard Hayford and Klutsey, Gifty Belinda and Sesenu, Edna and Tay, Georgina and Tibu, Faustina and Kemawor, Seyram and Gedzah, Isaac and Morkli, Esu Aku Catherine and Danyo, Stephen and Akakpo, Patrick Kafui},
  title = {Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana},
  journal = {PLOS Global Public Health},
  year = {2023},
  volume = {3},
  number = {4},
  pages = {e0001830},
  doi = {10.1371/journal.pgph.0001830}
}
Kostenlos starten →